Form 8-K - Current report:
SEC Accession No. 0001493152-24-025116
Filing Date
2024-06-25
Accepted
2024-06-25 17:00:13
Documents
16
Period of Report
2024-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 74571
2 ex10-1.htm EX-10.1 25565
3 ex10-2.htm EX-10.2 24129
4 ex10-3.htm EX-10.3 17737
  Complete submission text file 0001493152-24-025116.txt   329735

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE arth-20240619.xsd EX-101.SCH 3039
6 XBRL LABEL FILE arth-20240619_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE arth-20240619_pre.xml EX-101.PRE 22375
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3354
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 241069731
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)